Free Trial
NASDAQ:GOVX

GeoVax Labs (GOVX) Stock Price, News & Analysis

GeoVax Labs logo
$0.76 -0.03 (-3.21%)
As of 08/27/2025 04:00 PM Eastern

About GeoVax Labs Stock (NASDAQ:GOVX)

Key Stats

Today's Range
$0.75
$0.79
50-Day Range
$0.48
$0.96
52-Week Range
$0.43
$6.50
Volume
544,741 shs
Average Volume
860,982 shs
Market Capitalization
$12.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.50
Consensus Rating
Buy

Company Overview

GeoVax Labs Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

GOVX MarketRank™: 

GeoVax Labs scored higher than 33% of companies evaluated by MarketBeat, and ranked 749th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    GeoVax Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    GeoVax Labs has only been the subject of 1 research reports in the past 90 days.

  • Read more about GeoVax Labs' stock forecast and price target.
  • Earnings Growth

    Earnings for GeoVax Labs are expected to grow in the coming year, from ($4.49) to ($1.12) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GeoVax Labs is -0.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GeoVax Labs is -0.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    GeoVax Labs has a P/B Ratio of 4.21. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about GeoVax Labs' valuation and earnings.
  • Percentage of Shares Shorted

    23.71% of the float of GeoVax Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    GeoVax Labs has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GeoVax Labs has recently increased by 51.01%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    GeoVax Labs does not currently pay a dividend.

  • Dividend Growth

    GeoVax Labs does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    23.71% of the float of GeoVax Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    GeoVax Labs has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GeoVax Labs has recently increased by 51.01%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    GeoVax Labs has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for GeoVax Labs this week, compared to 1 article on an average week.
  • Search Interest

    Only 15 people have searched for GOVX on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.
  • MarketBeat Follows

    Only 7 people have added GeoVax Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GeoVax Labs insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.20% of the stock of GeoVax Labs is held by insiders.

  • Percentage Held by Institutions

    Only 6.09% of the stock of GeoVax Labs is held by institutions.

  • Read more about GeoVax Labs' insider trading history.
Receive GOVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GeoVax Labs and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GOVX Stock News Headlines

“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
GeoVax Labs, Inc. (GOVX) - Yahoo Finance
See More Headlines

GOVX Stock Analysis - Frequently Asked Questions

GeoVax Labs' stock was trading at $2.47 at the beginning of 2025. Since then, GOVX stock has decreased by 69.3% and is now trading at $0.7578.

GeoVax Labs Inc. (NASDAQ:GOVX) issued its quarterly earnings results on Monday, July, 28th. The company reported ($0.35) EPS for the quarter, topping the consensus estimate of ($0.41) by $0.06. The business had revenue of $0.85 million for the quarter, compared to analyst estimates of $0.37 million. GeoVax Labs had a negative net margin of 403.88% and a negative trailing twelve-month return on equity of 408.80%.
Read the conference call transcript
.

GeoVax Labs's stock reverse split before market open on Wednesday, January 31st 2024.The 1-15 reverse split was announced on Wednesday, January 31st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 31st 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of GOVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GeoVax Labs investors own include Plug Power (PLUG), FuelCell Energy (FCEL), Workhorse Group (WKHS), KALA BIO (KALA), Lipocine (LPCN), Fortress Biotech (FBIO) and Ovid Therapeutics (OVID).

Company Calendar

Last Earnings
7/28/2025
Today
8/27/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GOVX
CIK
832489
Employees
10
Year Founded
N/A

Price Target and Rating

High Price Target
$9.00
Low Price Target
$8.00
Potential Upside/Downside
+1,021.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$24.99 million
Net Margins
-403.88%
Pretax Margin
-403.88%
Return on Equity
-408.80%
Return on Assets
-279.89%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.03
Quick Ratio
2.03

Sales & Book Value

Annual Sales
$3.95 million
Price / Sales
3.06
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.18 per share
Price / Book
4.21

Miscellaneous

Outstanding Shares
15,930,000
Free Float
15,734,000
Market Cap
$12.07 million
Optionable
Not Optionable
Beta
3.27

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:GOVX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners